Journal News

ASBMB journals will be fully open access in 2021

ASBMB Today Staff
By ASBMB Today Staff
May 11, 2020

Earlier today, the American Society for Biochemistry and Molecular Biology announced that its three peer-reviewed journals will become, as of January, open access. You can read the announcement in full below. The society also created a page with frequently asked questions.


As elected, editorial and administrative leaders of the American Society for Biochemistry and Molecular Biology, we are pleased to announce that the society’s three highly regarded journals — Journal of Biological Chemistry, Molecular & Cellular Proteomics and Journal of Lipid Researchwill be fully open access beginning in January 2021.

The ASBMB exists to meet the needs and respond to the demands of its members, and our members, in line with the broader scientific community, have called for immediate and free public access to research published in ASBMB journals in order to reduce barriers to scientific knowledge and accelerate discoveries.

ASBMB journals have for years made accepted manuscripts immediately available for free as Papers in Press and have embargoed the final redacted versions of articles for subscribers for only a single year. In addition, authors have had the option to pay an additional fee for immediate open access of the final version of a paper or upload the accepted version for free to a public repository. As of January, the final versions of all articles will be immediately available to everyone, qualifying ASBMB journals as “gold” open access. This is important because an increasing number of funders of biomedical research are requiring its grantees to publish in only “gold” journals.

Our decision-making process was careful and consultative. During our months-long deliberations, we had to balance what is best for science and scientists with what is sustainable for a nonprofit organization. Ultimately, we determined that the ASBMB cannot achieve its goal of full open access alone, so we made the strategic decision to enter into an agreement with the commercial publisher Elsevier, which has experience transitioning subscription journals to full open access and the requisite technical expertise and infrastructure.

We want to emphasize that this agreement will not change the peer-review process at any of our journals. JBC, MCP and JLR remain committed to rigorous, fast and fair review — by active scientists.

We are happy to report, also, that the agreement will smooth the submission process for authors and reduce the cost of open-access publishing — for both members and nonmembers alike. It also will make our journals easier to read on mobile devices, discoverable on the platform ScienceDirect and, generally speaking, more nimble technologically.

Transitioning from a subscription model to an open-access model is complicated, but we know this is the right decision for the ASBMB. Throughout our deliberations, we kept focused on our goal: to make the high-quality papers we publish immediately and permanently available for everyone to read, download, copy and distribute.

We will share more information on the transition in the months to come. In the meantime, we hope that you will reach out to us if you have any questions or concerns.

Sincerely,

Gerald Hart (President, ASBMB)
Joan Conaway (Treasurer, ASBMB)
Sandra Weller (Chair, ASBMB Publications Committee)
Toni Antalis (President-elect, ASBMB)
Lila M. Gierasch (Editor-in-Chief, Journal of Biological Chemistry)
Alma Burlingame (Editor-in-Chief, Molecular & Cellular Proteomics)
Kerry-Anne Rye and Nicholas O. Davidson (Co-Editors, Journal of Lipid Research)
Barbara Gordon (Executive Director, ASBMB)
Nancy Rodnan (Senior Director, ASBMB Publications)
Steve Miller (Deputy Executive Director and Chief Financial Officer, ASBMB)

ASBMB Today Staff
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Unraveling the mysterious mutations that make delta the most transmissible COVID virus yet
News

Unraveling the mysterious mutations that make delta the most transmissible COVID virus yet

July 31, 2021

As of this week, the delta variant had caused at least 92% of the new infections in the United States, according to a research firm in Switzerland.

Cats communicate with the help of bacteria living in their butts
News

Cats communicate with the help of bacteria living in their butts

July 31, 2021

KittyBiome researchers want to study the cat microbiome to improve health and understand scent-based communication.

From the journals: JLR
Journal News

From the journals: JLR

July 29, 2021

Reversing alcoholism’s effects on lipid droplets. How HDL cholesterol might reduce COVID-19 risk. Shining light on the cholesterol–GPCR relationship. Read about recent papers on these topics in the Journal of Lipid Research.

Starved to death: Can dietary methionine combat cancer?
Journal News

Starved to death: Can dietary methionine combat cancer?

July 27, 2021

Scientists draw a connection between this essential amino acid and cancer lipid metabolism.

I’m fully vaccinated but feel sick – should I get tested for COVID-19?
News

I’m fully vaccinated but feel sick – should I get tested for COVID-19?

July 25, 2021

It’s impossible to know whether a vaccinated person is fully protected or could still develop a mild case if exposed to the coronavirus.

Research roundup: Olympics edition
Observance

Research roundup: Olympics edition

July 23, 2021

A snapshot of science relevant to sports in the spotlight at the Tokyo Games.